Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,519 | 57 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $240.06 | 7 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $204.78 | 5 | $0 (2023) |
| Abbott Laboratories | $167.29 | 1 | $0 (2024) |
| ATRICURE, INC. | $131.78 | 1 | $0 (2024) |
| Almatica Pharma LLC | $103.08 | 5 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $86.28 | 6 | $0 (2021) |
| SCILEX PHARMACEUTICALS INC. | $80.24 | 4 | $0 (2021) |
| RedHill Biopharma Inc. | $72.64 | 5 | $0 (2021) |
| Bausch Health US, LLC | $56.65 | 3 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $53.36 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $299.07 | 2 | Abbott Laboratories ($167.29) |
| 2023 | $843.92 | 32 | ABBVIE INC. ($240.06) |
| 2021 | $376.34 | 23 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($86.28) |
All Payment Transactions
57 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/14/2024 | ATRICURE, INC. | ATRICLIP LAA EXCLUSION SYSTEM (Device) | Food and Beverage | In-kind items and services | $131.78 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/27/2024 | Abbott Laboratories | PROCLAIM (Device) | Food and Beverage | In-kind items and services | $167.29 | General |
| Category: Neuromodulation | ||||||
| 12/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.35 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $22.38 | General |
| Category: ANTI-ANXIETY | ||||||
| 11/29/2023 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.01 | General |
| Category: ADHD | ||||||
| 11/21/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Neurology | ||||||
| 11/15/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.13 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $11.53 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 11/02/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: Central Nervous System | ||||||
| 11/01/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2023 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $20.98 | General |
| Category: Psychology/Psychiatric | ||||||
| 10/25/2023 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: INSOMNIA | ||||||
| 10/23/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: NEUROSCIENCE | ||||||
| 10/19/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2023 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: ANTI-ANXIETY | ||||||
| 10/17/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: CNS | ||||||
| 10/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: PSYCHIATRY | ||||||
| 10/12/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Neurology | ||||||
| 10/12/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.78 | General |
| Category: PSYCHIATRY | ||||||
| 10/11/2023 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Neurology | ||||||
| 10/11/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.10 | General |
| Category: PSYCHIATRY | ||||||
| 10/09/2023 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $25.49 | General |
| Category: Central Nervous System | ||||||
| 09/28/2023 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 09/18/2023 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 2 | 88 | 102 | $62,700 | $4,437 |
| 2020 | 3 | 199 | 305 | $189,650 | $8,333 |
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 56 | $42,000 | $3,087 | 7.3% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2021 | 39 | 46 | $20,700 | $1,350 | 6.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 101 | 160 | $120,000 | $4,774 | 4.0% |
| 99484 | Care management services for behavioral health conditions, at least 20 minutes clinical staff time | Office | 2020 | 87 | 134 | $60,300 | $2,906 | 4.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 11 | $9,350 | $652.32 | 7.0% |
About Aaron Kime, CRNP
Aaron Kime, CRNP is a Primary Care healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568486306.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Aaron Kime, CRNP has received a total of $1,519 in payments from pharmaceutical and medical device companies, with $299.07 received in 2024. These payments were reported across 57 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,519).
As a Medicare-enrolled provider, Kime has provided services to 287 Medicare beneficiaries, totaling 407 services with total Medicare billing of $12,770. Data is available for 2 years (2020–2021), covering 5 distinct procedure/service records.
Practice Information
- Specialty Primary Care
- Location Coraopolis, PA
- Active Since 07/26/2006
- Last Updated 10/09/2018
- Taxonomy Code 363LP2300X
- Entity Type Individual
- NPI Number 1568486306
Products in Payments
- VRAYLAR (Drug) $240.06
- REXULTI (Drug) $221.88
- PROCLAIM (Device) $167.29
- ATRICLIP LAA EXCLUSION SYSTEM (Device) $131.78
- RELISTOR (Drug) $86.28
- LOREEV XR (Drug) $81.52
- ZTLido (Drug) $80.24
- Movantik (Drug) $72.64
- APLENZIN (Drug) $56.65
- XTAMPZA (Drug) $53.36
- Azstarys (Drug) $50.03
- Austedo XR (Drug) $45.98
- QUVIVIQ (Drug) $45.76
- REYVOW (Drug) $34.71
- HETLIOZ (Drug) $24.42
- SERTRALINE HCL (Drug) $21.56
- Auvelity (Drug) $20.98
- LEVORPHANOL TARTRATE (Drug) $19.12
- Dyanavel XR (Drug) $19.01
- LYBALVI (Drug) $16.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.